Search results
A new COVID variant is dominant in the US: What are its symptoms?
TODAY via Yahoo News· 15 hours agoThe new "FLiRT" COVID-19 variants, including KP.3 and KP.2, are spreading in the United States. Will...
COVID summer guide: How to navigate symptoms, variants and vaccines this season
Yahoo Life· 2 days agoWho should wait, and who should get vaccinated now? The CDC advises that everyone ages 5 and older...
Moderna’s New Flu-COVID Combi mRNA Vaccine Outperforms Separate Shots In Trials
IFLScience· 4 days agoModerna became a household name thanks to the success of its mRNA vaccine against COVID-19. Along...
COVID vaccine companies told to focus on KP.2 variant for fall shots, per FDA announcement
Fox News via Yahoo News· 5 hours agoThe U.S. Food and Drug Administration (FDA) has recommended thatCOVID vaccine manufacturers update...
Trump’s Anti-Vaccine Problem
New York Times· 18 hours agoFour years later, a different aspect of his handling of the pandemic has emerged as a sensitive subject with another slice of the electorate: his own...
FDA advises Covid vaccine makers to target KP.2 for fall shots
NBC NEWS· 2 days agoThe Food and Drug Administration said Thursday it had advised drugmakers to update the Covid ...
A new Alzheimer's drug, combined COVID and flu vaccine update, and salmonella concerns. 3 health...
Yahoo Life· 2 hours agoModerna's combo shot wins over separate ones Moderna’s latest medical innovation is packing a...
Another COVID vaccine? Yes, and here’s why
San Jose Mercury News· 4 days agoThis fall, prepare for the latest round of COVID vaccine Whac-a-Mole. Protection against both infection and severe illness is waning. “Effectiveness has...
Combo COVID/flu vaccine elicits higher immune response in trial
United Press International via Yahoo News· 5 days agoAn experimental vaccine that could offer one-stop prevention for both COVID-19 and influenza is...
COVID-flu combination vaccine shows positive results in late-stage trial, Moderna says
WPTZ Burlington· 5 days agoCalling the outcome of the late-stage trial “breakthrough results,” Moderna’s Chief Medical Affairs...